CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 14  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0968
LYS 10.0154
GLU 20.0222
LEU 30.0179
ARG 40.0186
CYS 50.0221
GLN 60.0221
CYS 70.0165
ILE 80.0294
LYS 90.0287
THR 100.0157
TYR 110.0138
SER 120.0182
LYS 130.0188
PRO 140.0131
PHE 150.0120
HIS 160.0208
PRO 170.0139
LYS 180.0240
PHE 190.0178
ILE 200.0134
LYS 210.0158
GLU 220.0125
LEU 230.0079
ARG 240.0225
VAL 250.0213
ILE 260.0225
GLU 270.0194
SER 280.0103
GLY 290.0069
PRO 300.0181
HIS 310.0083
CYS 320.0066
ALA 330.0080
ASN 340.0135
THR 350.0168
GLU 360.0177
ILE 370.0122
ILE 380.0143
VAL 390.0090
LYS 400.0098
LEU 410.0074
SER 420.0166
ASP 430.0103
GLY 440.0134
ARG 450.0138
GLU 460.0153
LEU 470.0121
CYS 480.0098
LEU 490.0020
ASP 500.0083
PRO 510.0146
LYS 520.0235
GLU 530.0161
ASN 540.0147
TRP 550.0088
VAL 560.0065
GLN 570.0086
ARG 580.0067
VAL 590.0065
VAL 600.0041
GLU 610.0118
LYS 620.0146
PHE 630.0044
LEU 640.0224
LYS 650.0496
ARG 660.0165
ALA 670.0507
GLU 680.0968
ASN 690.0956

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.